Tango Therapeutics Inc. TNGX
$32.92
▲ +3.76% 24H
About
Tango Therapeutics Inc. is a biotechnology company focused on discovering and developing precision oncology therapies. The company applies synthetic lethality and target discovery approaches to identify cancer dependencies that can be addressed with medicines designed for specific tumor types. Its current pipeline cent…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees137
TickerTNGX
Statistics
Market Cap$4.75B
Revenue (TTM)$62.4M
Net Income-$101.6M
Net Margin-162.9%
EPS$-0.87
P/E-34.26
P/S80.10
P/B12.39
EV/EBITDA-36.55
ROE-38.4%
Dividend Yield—
Price$32.92
Data: Twelve Data · Revenue = mcap / P/S